From Pulse 2.0 · Amit Chowdhry · · 50s
Kos Partners Invests In Golden Age Health
Kos Biotechnology Partners invests in Golden Age Health to expand rare disease access across Asia.
In brief
Kos Biotechnology Partners invests in Golden Age Health to expand rare disease access across Asia. Kos Biotechnology Partners invested in Golden Age Health to expand rare disease access across Greater China and the Asia-Pacific region. Originally reported by Pulse 2.0.
Strategic Investment
Kos Biotechnology Partners made a strategic investment in Golden Age Health through its inaugural Kos BioVentures fund.
Alex Tzoukas Joins Board
Alex Tzoukas, Kos Biotechnology Partners Managing Partner and Co-Founder, joins Golden Age Health’s board of directors.
Golden Age Health Mission
Golden Age Health is a Singapore-headquartered company focused on rare and specialty disease therapies for underserved populations in Greater China, Southeast Asia, and Gulf markets.
Expansion Plans
The investment supports Golden Age Health’s expansion across Greater China and the Asia-Pacific region with cross-border biotech innovation movement.
In short
Kos Biotechnology Partners invested in Golden Age Health to expand rare disease access across Greater China and the Asia-Pacific region.
